Please enable Javascript
Testicular, Penile, and Rare Malignancies
Advertisement
Is Surgery the Right Approach for Primary RPLND for Stage II Seminoma?
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
February 27, 2023
Researchers determined the surgical efficacy of RPLND and evaluated recurrence after primary RPLND for CS IIA/IIB seminoma.
Read More
Posttreatment Recurrence and Survival for Locally Advanced Penile Cancer
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
January 12, 2023
A study analyzed 228 patients with penile cancer who underwent pelvic lymph node treatment with curative intent.
Read More
PROs Help Guide Comprehensive Care Plans for Survivors of Testicular Cancer
Zachary Bessette
Testicular, Penile, and Rare Malignancies
|
December 27, 2022
Results from a single-institution trial support using surveys to inform comprehensive plans for testicular cancer survivors.
Read More
Dynamic Sentinel Lymph Node Biopsies for Penile Cancer
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
December 8, 2022
Researchers reviewed the efficacy of sentinel lymph node biopsy as well as further radical inguinal lymph node dissection.
Read More
De-Escalated Combo Treatment for Seminoma Warrants Further Research
Leah Lawrence
Testicular, Penile, and Rare Malignancies
|
October 31, 2022
Progression-free survival for stage IIA and stage IIB seminoma was improved with single-dose carboplatin and radiotherapy.
Read More
Certain Ethnic Groups Had Higher Rates of HPV-Associated Penile, Anorectal Cancer
Leah Lawrence
Testicular, Penile, and Rare Malignancies
|
October 4, 2022
Hispanic males had the highest incidence of HPV-associated penile cancers and were diagnosed at later stages.
Read More
Neoadjuvant Platinum-Based Chemotherapy Effective for Metastatic Penile SCC
Leah Lawrence
ESMO 2022
|
September 16, 2022
Neoadjuvant platinum-based chemotherapy has been found effective for treating metastatic penile squamous cell carcinoma.
Read More
Neurodevelopmental Disorders Associated With Risk for Testicular Seminoma
Leah Lawrence
ESMO 2022
|
September 16, 2022
A new study has found an association between neurodevelopmental disorders and testicular seminoma.
Read More
Testicular Cancer Survivors at Increased Risk for Skin Cancer
Leah Lawrence
Testicular, Penile, and Rare Malignancies
|
August 2, 2022
Many TGCT survivors are referred for life-long monitoring due to an increased risk for skin cancer and melanoma.
Read More
Cancer in the Faroe Islands from 1960-2019—Incidence, Mortality, and Comparisons With the Other Nordic Countries
GU Oncology Now Editors
Urothelial Carcinoma
|
June 3, 2022
In this paper, we present age-standardized cancer incidence and mortality rates in the Faroe Islands.
Read More
Clinical Effect of Retroperitoneal Laparoscopic Radical Nephrectomy on Renal Cell Carcinoma, the Influence of Renal Function, and the Influencing Factors of Recurrence
GU Oncology Now Editors
Renal Cell Carcinoma
|
June 3, 2022
RLRN has been widely used in the surgical treatment of renal cancer due to small wound, less bleeding, and rapid recovery.
Read More
Arterioureteral Fistula in the Setting of Radical Cystoprostatectomy and Ileal Conduit Creation
GU Oncology Now Editors
Testicular, Penile, and Rare Malignancies
|
June 2, 2022
Arterioureteral fistulas (AUF) following ileal conduit reconstruction are rare and not well-studied.
Read More
An Integrated Systematic Analysis and the Clinical Significance of Hepcidin in Common Malignancies of the Male Genitourinary System
GU Oncology Now Editors
Renal Cell Carcinoma
|
June 1, 2022
Researchers determined the underlying oncogenic functions of hepcidin in common male genitourinary system tumors.
Read More
Detection Rates of Urogenital Cancers and Benign Pathology in Men Presenting With Hematospermia
GU Oncology Now Editors
Urothelial Carcinoma
|
May 31, 2022
Hematospermia, although often found to be a benign condition, can be an alarming sign.
Read More
A Large Primary Retroperitoneal Synovial Sarcoma: A Case Report of a Huge Malignant Tumor
GU Oncology Now Editors
Testicular, Penile, and Rare Malignancies
|
May 31, 2022
Synovial Sarcoma (SS) is a rare soft-tissue malignancy. Only about 15% of SS originates from the retroperitoneum.
Read More
GSTM1/GSTT1 Is Essential for Reducing Cisplatin Ototoxicity in CBA/CaJ Mice
GU Oncology Now Editors
Testicular, Penile, and Rare Malignancies
|
May 27, 2022
Cisplatin is a widely used chemotherapeutic agent, but its utility is limited because of cisplatin-induced ototoxicity.
Read More
Efficacy of Pembrolizumab in Patients With Advanced Cancer of Unknown Primary (CUP): A Phase 2 Non-Randomized Clinical Trial
GU Oncology Now Editors
Testicular, Penile, and Rare Malignancies
|
May 27, 2022
Cancer of unknown primary (CUP) is an aggressive rare malignancy with limited treatment options.
Read More
Targeting Inhibitor of Apoptosis Proteins (IAPs) With IAP Inhibitors Sensitises Malignant Rhabdoid Tumour Cells to Cisplatin
GU Oncology Now Editors
Testicular, Penile, and Rare Malignancies
|
May 26, 2022
Malignant rhabdoid tumor is a rare, aggressive pediatric malignancy most commonly diagnosed in those below the age of three.
Read More
The Uromigos Episode 69: Testis Cancer Christmas Special—2020 Year in Review
The Uromigos
The Uromigos
|
December 9, 2020
Christian Kollmannsberger gets into the Christmas spirit by discussing highlights of 2020 in the world of testis cancer.
Listen Now
The Uromigos Episode 51: Virtual World Tour—Norway With Jan Oldenburg Discussing Key Topics in Testis Cancer
The Uromigos
The Uromigos
|
July 18, 2020
Dr. Jan Oldenburg discusses stage 1 testis cancer treatment choices, the dilemma of high-dose therapy for relapse, and more.
Listen Now
Advertisement
Advertisement
Advertisement